InnovAge Appoints Jennifer Browne as President and Chief Operating Officer

Go back to InnovAge Appoints Jennifer Browne as President and Chief Operating Officer
Innovus Pharmaceuticals, Inc. (NASDAQ: INNV) Delayed: 9.19 -0.05 (0.54%)
Previous Close $9.24    52 Week High $0.66 
Open $9.23    52 Week Low $0.03 
Day High $9.33    P/E N/A 
Day Low $9.14    EPS $-0.20 
Volume 593,063